Circulating adiponectin levels are decreased in obesity and type 2 diabetes and downregulation of adiponectin and its receptors is associated with insulin resistance and diabetes, as well as increased risk of HTN and coronary artery disease (174, 176). Here, ADIPOQ is linked to Obesity.